Product Information

BACLOFEN 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0696 per EA under NDC 16571016901. Its NADAC has been published 120 times since Aug 7, 2024.

FDA first approved this application on Mar 5, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BACLOFEN 5 MG TABLET

BACLOFEN
$0.0696per EA

Strength

5 mg/1

NDC

16571016901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BACLOFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA214374

FDA Approved

3/5/2021

TE Code

AB

On Market Since

3/1/2024

Pharmacological Classes

GABA A Agonists
GABA B Agonists
gamma-Aminobutyric Acid-ergic Agonist

Price Statistics

The NADAC for BACLOFEN 5 MG TABLET has been published 120 times since Aug 7, 2024, and over the history we have for it it has declined 46.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0696 per EA
All-time high$0.1440 (Sep 11, 2024)
All-time low$0.0631 (Jul 22, 2026)
52-week high$0.1022
52-week low$0.0631
Median price$0.0963
Average price$0.0940
Largest weekly change-17.4% (Dec 18, 2024)
Weeks tracked120
Tracking sinceAug 7, 2024

Price History

1W

+1.7%

1M

+2.4%

3M

+1.7%

6M

+3.9%

1Y

-32.1%

3Y

N/A

5Y

N/A

All

-46.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BACLOFEN 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BACLOFEN 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0696 per EA (NDC 16571016901), effective Nov 18, 2026.

How has the price of BACLOFEN 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BACLOFEN 5 MG TABLET has declined 46.1%. It has been tracked across 120 weekly CMS publications since Aug 7, 2024.

What are the highest and lowest recorded NADAC prices for BACLOFEN 5 MG TABLET?

Since Aug 7, 2024, the NADAC for BACLOFEN 5 MG TABLET has ranged from a low of $0.0631 (Jul 22, 2026) to a high of $0.1440 (Sep 11, 2024), with a median of $0.0963 per EA.

Are there cheaper alternatives to BACLOFEN 5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BACLOFEN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BACLOFEN 5 MG TABLET?

BACLOFEN 5 MG TABLET (NDC 16571016901) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.